Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sarkar

Showing results (571-580 of 593) with videos related to

Pageof 60
Sort By:
Current Cancer Drug Targets|April 8, 2010
Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, A Aboukameel, et al.
Journal of Cellular Physiology|April 27, 2007
Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cellsXiaohua Li, Di Chen, Shuping Yin, et al.
BMC Systems Biology|September 6, 2013
Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype induced by SNAIL-inhibitor GN-25Asfar S Azmi, Aliccia Bollig-Fischer, Bin Bao, et al.
Translational Oncology|April 2, 2013
CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growthShuo Wang, Yanning Wu, Yuning Hou, et al.
Cancer Research|January 21, 2006
Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancerYuxiang Zhang, Sanjeev Banerjee, Zhiwei Wang, et al.
Current Drug Targets|November 13, 2012
Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cellsJun Xia, Qiaoling Duan, Aamir Ahmad, et al.
Molecular Cancer Therapeutics|June 3, 2010
ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cellsJyoti Nautiyal, Yingjie Yu, Amro Aboukameel, et al.
American Journal of Translational Research|April 13, 2016
Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patientsClara Hwang, Seema Sethi, Lance K Heilbrun, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 15, 2011
Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injuryGilda G Hillman, Vinita Singh-Gupta, Lindsay Runyan, et al.
Pancreas|January 22, 1998
Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agentsR M Mohammad, M C Dugan, A N Mohamed, et al.
Pageof 60

Showing results (571-580 of 593) with videos related to

Sort By:
Pageof 60
Current Cancer Drug Targets|April 8, 2010
Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, A Aboukameel, et al.
Journal of Cellular Physiology|April 27, 2007
Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cellsXiaohua Li, Di Chen, Shuping Yin, et al.
BMC Systems Biology|September 6, 2013
Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype induced by SNAIL-inhibitor GN-25Asfar S Azmi, Aliccia Bollig-Fischer, Bin Bao, et al.
Translational Oncology|April 2, 2013
CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growthShuo Wang, Yanning Wu, Yuning Hou, et al.
Cancer Research|January 21, 2006
Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancerYuxiang Zhang, Sanjeev Banerjee, Zhiwei Wang, et al.
Current Drug Targets|November 13, 2012
Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cellsJun Xia, Qiaoling Duan, Aamir Ahmad, et al.
Molecular Cancer Therapeutics|June 3, 2010
ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cellsJyoti Nautiyal, Yingjie Yu, Amro Aboukameel, et al.
American Journal of Translational Research|April 13, 2016
Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patientsClara Hwang, Seema Sethi, Lance K Heilbrun, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 15, 2011
Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injuryGilda G Hillman, Vinita Singh-Gupta, Lindsay Runyan, et al.
Pancreas|January 22, 1998
Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agentsR M Mohammad, M C Dugan, A N Mohamed, et al.
Pageof 60